Labshake search

5201 - 5250 of 10000+ citations for Anti CD337 Antibody since 2019

• The Firre locus produces a trans-acting RNA molecule that functions in hematopoiesis

  Jordan P. Lewandowski, et al., bioRxiv - Immunology 2019

  Quote: ... PE anti-mouse CD3 (Biolegend, 100205), PE/Cy7 anti-mouse/human CD44 (Biolegend ...
• The Firre locus produces a trans-acting RNA molecule that functions in hematopoiesis

  Jordan P. Lewandowski, et al., bioRxiv - Immunology 2019

  Quote: ... APC anti-mouse CD19 (Biolegend, 115512), Alexa Fluor 488 anti-mouse NK-1.1 (Biolegend ...
• Early neuronal processes interact with glia to establish a scaffold for orderly innervation of the cochlea

  N. R. Druckenbrod, et al., bioRxiv - Developmental Biology 2019

  Quote: ... Rabbit anti-Tuj (Biolegend, 1:1000), Goat anti-GFP FITC (Abcam 1:500) ...
• Myo1e modulates the recruitment of B cells to inguinal lymph nodes

  Daniel Alberto Girón-Pérez, et al., bioRxiv - Immunology 2019

  Quote: ... anti-TLR-4 (clone TF901, BioLegend), anti-CXCR4 (clone 2G8 ...
• Myo1e modulates the recruitment of B cells to inguinal lymph nodes

  Daniel Alberto Girón-Pérez, et al., bioRxiv - Immunology 2019

  Quote: ... anti-CD62L (clone DREG-56, BioLegend), anti-TLR-4 (clone TF901 ...
• Myo1e modulates the recruitment of B cells to inguinal lymph nodes

  Daniel Alberto Girón-Pérez, et al., bioRxiv - Immunology 2019

  Quote: ... anti-LFA-1 (clone Hl111, BioLegend), anti-CD62L (clone DREG-56 ...
• The IL-12 and IL-23-Dependent NK Cell Response is Essential For Protective Immunity Against Secondary Toxoplasma gondii Infection.

  Daria L Ivanova, et al., bioRxiv - Immunology 2019

  Quote: ... and anti-IL-23p19 (MMp19B2, Biolegend) on d −1 ...
• BKV clearance time correlates with exhaustion state and T-cell receptor repertoire shape of BKV-specific T-cells in renal transplant patients

  Ulrik Stervbo, et al., bioRxiv - Immunology 2019

  Quote: ... anti-PD1-BV710 (Clone: EH12.2H7; Biolegend), and anti-TIM3-APC (Clone ...
• Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci

  Maria Gutierrez-Arcelus, et al., bioRxiv - Genomics 2019

  Quote: ... BV650 anti-CD19(Biolegend, Clone: HIB19), PerCP-Cy5.5 anti-CD45R0 (Biolegend ...
• Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci

  Maria Gutierrez-Arcelus, et al., bioRxiv - Genomics 2019

  Quote: ... BV605 anti-CD3(Biolegend, Clone: OKT3), BV785 anti-CD38 (Biolegend ...
• Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci

  Maria Gutierrez-Arcelus, et al., bioRxiv - Genomics 2019

  Quote: ... BV510 anti-CD27 (Biolegend, Clone: O323), BV605 anti-CD3(Biolegend ...
• TORC1 regulates vacuole membrane composition through ubiquitin- and ESCRT-dependent microautophagy

  Xi Yang, et al., bioRxiv - Cell Biology 2019

  Quote: ... anti-HA (1:1000; 16B12, BioLegend), mouse anti-MYC(1:500 ...
• Light-entrained and brain-tuned circadian circuits regulate ILC3 and gut homeostasis

  Cristina Godinho-Silva, et al., bioRxiv - Immunology 2019

  Quote: ... anti-streptavidin fluorochrome conjugates from Biolegend; anti-α4β7 (DATK32) ...
• Neonatal-derived IL-17 producing dermal γδ T cells are required to prevent spontaneous atopic dermatitis

  Nicholas Spidale, et al., bioRxiv - Immunology 2019

  Quote: ... anti-GL7 Alexa Fluor 488 (BioLegend), and anti-CD11c Brilliant Violet 421 (BioLegend) ...
• Transcriptome Dynamics Reveals Progressive Transition from Effector to Memory in CD4⁺ T cells

  Megan S. F. Soon, et al., bioRxiv - Immunology 2019

  Quote: ... rat anti-mouse IgD-AF647 (Biolegend), and biotinylated peanut agglutinin (PNA ...
• The In Vivo Source of Type I and Type III IFNs is Pathogen Dependent

  Marvin J. Sandoval, et al., bioRxiv - Immunology 2021

  Quote: ... anti-mouse CD11b-APC-Cy7 (BioLegend), and anti-mouse Siglec F-PE (BD Pharmingen) ...
• Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies

  S. Jordan Kerns, et al., bioRxiv - Cancer Biology 2021

  Quote: ... and anti-human CD69 APC (BioLegend).
• Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

  Daniel Neumeier, et al., bioRxiv - Immunology 2021

  Quote: ... anti-IgK-Brilliant Violet421 (BioLegend, 409511) and OVA-AlexaFluor647 (0.86 mg/ml ...
• Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination

  Alice Cho, et al., bioRxiv - Immunology 2021

  Quote: ... anti-CD71- PerCP-Cy5.5 (Biolegend, 334114), anti- IgG-PECF594 (BD biosciences ...
• The In Vivo Source of Type I and Type III IFNs is Pathogen Dependent

  Marvin J. Sandoval, et al., bioRxiv - Immunology 2021

  Quote: ... anti-mouse CD3-APC Cy7 (BioLegend), anti-mouse CD11c-APC (eBioscience) ...
• The In Vivo Source of Type I and Type III IFNs is Pathogen Dependent

  Marvin J. Sandoval, et al., bioRxiv - Immunology 2021

  Quote: ... anti-mouse F4/80-APC (BioLegend), anti-mouse CD11c-PerCPCy5.5 (BioLegend) ...
• Platelets are dispensable for the ability of CD8+ T cells to accumulate, patrol, kill and reside in the liver

  James H. O’Connor, et al., bioRxiv - Immunology 2021

  Quote: ... and anti-CD8 (clone 53.67- Biolegend). Cultures were then analysed using Amnis ImageStream®X (Merck Millipore).
• Platelets are dispensable for the ability of CD8+ T cells to accumulate, patrol, kill and reside in the liver

  James H. O’Connor, et al., bioRxiv - Immunology 2021

  Quote: ... anti-CD3 (clone 17.A2- Biolegend). Samples were then resuspended in FACs buffer with viability dye (7-AAD ...
• A transmissible γδ intraepithelial lymphocyte hyperproliferative phenotype is associated with the intestinal microbiota and confers protection against acute infection

  Luo Jia, et al., bioRxiv - Immunology 2021

  Quote: ... and anti-Vγ1 (clone 2.11, BioLegend) or a Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit (Invitrogen) ...
• Cyclophilin A regulates protein phase separation and mitigates haematopoietic stem cell aging

  Laure Maneix, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD150 (clone TC15-12F12.2, BioLegend), anti-CD127 (clone SB/199 ...
• Cyclophilin A regulates protein phase separation and mitigates haematopoietic stem cell aging

  Laure Maneix, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD127 (clone SB/199, BioLegend) and anti-CD45.1/2 (clones A20 and 104 ...
• Interleukin-11 is a Marker for Both Cancer- and Inflammation-Associated Fibroblasts that Contribute to Colorectal Cancer Progression

  Takashi Nishina, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-podoplanin (BioLegend, 127414, clone 8.1.1), anti-TER-119 (BioLegend ...
• Interleukin-11 is a Marker for Both Cancer- and Inflammation-Associated Fibroblasts that Contribute to Colorectal Cancer Progression

  Takashi Nishina, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-EpCAM (BioLegend, 118214, clone G8.8), anti-Thy1.2 (20-0903 ...
• Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger Cyclin K degradation

  Lu Lv, et al., bioRxiv - Biochemistry 2020

  Quote: ... anti-HA (BioLegend, 901533, 1:4,000), anti-RNA polymerase II subunit B1 (phospho CTD Ser-2 ...
• The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28

  Yannick D. Muller, et al., bioRxiv - Bioengineering 2020

  Quote: ... anti-CD28 APC (clone 28.2, Biolegend), CD8 APC-Cy7 (clone SK1 Biolegend) ...
• The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28

  Yannick D. Muller, et al., bioRxiv - Bioengineering 2020

  Quote: ... anti-CD71 FITC (clone CY1G4, Biolegend), anti Myc FITC or APC (clone 9B11 ...
• Antibody-based delivery of Interleukin-9 to neovascular structures: therapeutic evaluation in cancer and arthritis

  Baptiste Gouyou, et al., bioRxiv - Bioengineering 2020

  Quote: ... or rat anti-mCD335 (NKp46) (Biolegend). Goat anti-rat IgG Alexa FluorTM 488 (Invitrogen ...
• G-baToN: a versatile reporter system for cancer cell-stromal cell interactions

  Rui Tang, et al., bioRxiv - Bioengineering 2020

  Quote: ... or anti-Sirpa-AF467 (Biolegend, 144027) (for cardiomyocyte ...
• The solute carrier MFSD1 decreases β1 integrin’s activation status and thus tumor metastasis

  Marko Roblek, et al., bioRxiv - Cancer Biology 2021

  Quote: ... anti-LAMP1 (clone 1D4B, BioLegend, #121601), anti-cleaved caspase 3 (Cell Signaling Technology ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PE-Cy5 anti-mouse CD4 (BioLegend), PE-Cy7 anti-mouse CD169 (BioLegend) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PerCP-Cy5.5 anti-mouse CD45 (BioLegend), PerCp-eFluor711 anti-mouse CD80 (Invitrogen) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PE-Cy7 anti-mouse CD169 (BioLegend), APC anti-mouse FoxP3 (Invitrogen) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... incubation in anti-PE nanobeads (BioLegend) occurred ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... PE-Dazzle594 anti-mouse CD25 (BioLegend), PE-Cy5 anti-mouse CD4 (BioLegend) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... incubation in anti-APC nanobeads (BioLegend) and sorting ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... BV711 anti-mouse Ly-6C (BioLegend), BV750 anti-mouse CD45R/B220 (BioLegend) ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... BV650 anti-mouse F4/80 (BioLegend), BV650 anti-mouse MHC II (IA-IE ...
• Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

  Jacqueline A. Burke, et al., bioRxiv - Bioengineering 2020

  Quote: ... BV750 anti-mouse CD45R/B220 (BioLegend), BV785 anti-mouse CD11b (BioLegend) ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD36 (1:100; Biolegend #336203), anti-CD146 (1:200 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD45 (1:100; BioLegend #304005), anti-PDGFRβ (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD31 (1:100; BioLegend #303103), anti-CD45 (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-CD146 (1:100; BioLegend #342011), anti-FAP (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-PDGFRβ (1:100; BioLegend #323605), anti-PDGFRα (1:100 ...
• Single-cell analysis reveals diverse stromal subsets associated with immune evasion in triple-negative breast cancer

  Sunny Z. Wu, et al., bioRxiv - Cancer Biology 2020

  Quote: ... anti-PDGFRα (1:100; BioLegend #323507) and anti-CD146 (1:100 ...
• Control of Neutrophil activation through Semaphorin 7A-Plexin C1 is essential for immune defense during pulmonary sepsis

  Tiago Granja, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-CD62L PerCP/Cy5.5 (BioLegend #104431) and rat anti-mouse activated GPIIb/IIIa PE (Emfret ...